Trial intelligence / Profile preview

Topical Lidocaine vs IV Fentanyl for Intubation Stress

NCT07533643Completed

Sponsor
Kasr Al Ainy Hospital
Start
Aug 2025
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Maximum change in systolic blood pressure. Started Aug 2025; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray

Beyond the preview

Go deeper on NCT07533643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07533643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call